NYSE: PATHUipath Inc Stock
$18.24+0.31 (+1.73%)
Updated Jun 2, 2023
Shares of companies in the... find out Why PATH Price Moved with a free WallStreetZen account
Why Price MovedPATH Price
$18.24
Fair Value Price
N/A
Market Cap
$10.17B
52 Week Low
$10.40
52 Week High
$22.30
P/E
-30.4x
P/B
5.3x
P/S
7.95x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.06B
Earnings
-$328.35M
Gross Margin
83%
Operating Margin
-30%
Profit Margin
-31%
Debt to Equity
0.42
Operating Cash Flow
-$10M
Beta
1.99
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PATH Overview
UiPath Inc. offers an end-to-end platform customers use to build, manage, run, engage, measure, and govern automations across departments within an organization. The platform enables software robots (Robotic Process Automation) to perform an array of actions (logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases). The company's platform interacts with and automates processes across a company's existing enterprise stack. UiPath was founded in 2005 and is headquartered in New York, NY.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PATH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PATH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PATH is good value based on its book value relative to its share price (5.3x), compared to the US Software - Infrastructure industry average (11.98x)
P/B vs Industry Valuation
PATH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PATH due diligence checks available for Premium users.
Be the first to know about important PATH news, forecast changes, insider trades & much more!
PATH News
Valuation
PATH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-30.4x
Industry
31.08x
Market
52.74x
PATH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.3x
Industry
11.98x
PATH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PATH's financial health
Profit margin
Revenue
$308.5M
Net Income
-$27.7M
Profit Margin
-9%
PATH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PATH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.7B
Liabilities
$815.0M
Debt to equity
0.42
PATH's short-term assets ($2.34B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PATH's short-term assets ($2.34B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PATH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$94.0M
Investing
-$126.5M
Financing
-$16.9M
PATH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PATH vs Software Infrastructure Stocks
Uipath Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.